Cytological Spectrum and Bethesda Classification of Thyroid Lesions at a Tertiary Care Hospital in Central India - Cureus
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Cureus
Related articles
Bethesda Foundation encouraged after meeting with Health Minister - SteinbachOnline
Left to Right: Alisa Harder (Executive Director of the Bethesda Foundation), Board Chair Chris Goertzen, Manitoba Health Minister Uzoma Asagwara, Board Director Keith Unger, Board Vice Chair Waldo Neustaedter. (Photo Credit: Facebook.com/bethesdafoundation) The Bethesda Foundation board chair says they were encouraged after meeting with Manitoba Health Minister Uzoma Asagwara and the deputy minister to discuss health-care needs in Steinbach and the southeast.
Ilika, Genflow Biosciences, EnergyPathways, Ariana Resources, Tertiary Minerals, Light Science Technologies - Small Cap Week in Review - Proactive financial news
Ilika PLC (AIM:IKA, OTCQX:ILIKF) has completed its PRIMED programme, boosting Goliath battery performance. It's now focused on early revenue from its 10Ah cell, with interest from defence, e-bike and automotive partners. Watch more Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) says its SLAB trial in ageing dogs has hit its primary endpoint. The CEO calls it a big accomplishment for the company's SIRT6 therapy platform. Watch more
0 comments
No comments yet. Be the first to share your thoughts!